KPTIQ

0.03157.08%
SS

Sharon Shacham

Co-Founder & Chairman of Scientific Advisory Board

Dr. Sharon Shacham, Ph.D., MBA, is Independent Director of Nasus Pharma Ltd. from August 13, 2025. She serves as Managing Partner at E44 GP Ltd. She was Co-Founder & Managing Partner at E44 GP Ltd. She co-founded Karyopharm Therapeutics Inc. in 2008 and has been its Chief Scientific Officer since December 2012 and served as its President since December 2013 until May 3, 2021. She has been an Independent Director at Acrivon Therapeutics, Inc. since October 2020. Dr. Shacham has served as a director at Acrivon Theraputics, Inc. since May 2021. Dr. Shacham joined the Acrivon Therapeutics, Inc. in October 2020. Dr. Shacham served as the President of Research & Development at Karyopharm Therapeutics Inc. since December 2012 to April 2021. She served as President and Chief Executive Officer at Karyopharm Therapeutics Inc. from October 2010 to January 2011 and its Head of Research & Development from October 2010 to December 2012. Dr. Shacham has led Karyopharm's scientific progress since inception. Prior to joining Karyopharm, from 2000 to April 2009, she was Senior Vice President of Drug Development at Epix Pharmaceuticals, Inc., which underwent liquidation proceedings in 2009 and Director, Algorithm and Software Development at Predix Pharmaceuticals Inc. which merged into Epix Pharmaceuticals in 2006, where she led the company's efforts in GPCR modeling, computational chemistry, lead optimization and development of clinical trials. She also served as Vice President of Drug Development and Product Leadership of EPIX Pharmaceuticals Inc. Dr. Shacham serves as the Chairman of Scientific Advisory Board at Karyopharm Therapeutics Inc. and served as its Co-Chairman of Scientific Advisory Board. She serves as and director of Protai Therapeutics since January 2023. She served as Director of Karyopharm Therapeutics Inc. Dr. Shacham has published numerous scientific papers. She received a B.Sc. in Chemistry (Magna Cum Laude) from Tel Aviv University, a Ph.D. in computational biophysics & biochemistry from Tel Aviv University and an MBA from Tel Aviv University.

Positions